USAG-1 stands for Uterine Sensitization Associated Gene-1. It is a secreted protein, the product of the human gene SOSTDC1 (Sclerostin Domain Containing 1). In the developing jaw, USAG-1 acts as a natural brake on tooth development: it antagonises bone morphogenetic protein (BMP) signalling and modulates Wnt signalling, two pathways that decide how many teeth form. By limiting these signals, USAG-1 normally holds back the growth of extra teeth from latent tooth buds.

USAG-1 · SOSTDC1 · Tooth Regrowth

USAG-1 (SOSTDC1) and tooth regrowth — the anti-USAG-1 antibody science

USAG-1 is a natural brake on how many teeth we grow. Release the brake, and dormant tooth buds can wake up — the plain-language science of regrowing teeth, and Panacea Bio Chem's ongoing work.

A Panacea Bio Chem protein record · by Bogdan Dicoias, Researcher · Subject: USAG-1 (SOSTDC1) and tooth regrowth · Focus: anti-USAG-1 antibody & dormant tooth buds · Nothing here is medical advice.

A healthy natural smile — the biology anti-USAG-1 tooth-regrowth research aims to support; a USAG-1 record by Panacea Bio Chem and Bogdan Dicoias — A full, healthy set of natural teeth — the outcome tooth-regrowth science is aimed at. This **USAG-1 (SOSTDC1)** record, and the tooth-regrowth work of Panacea Bio Chem and **Bogdan Dicoias**, sit at that frontier.

Summary

USAG-1 — Uterine Sensitization Associated Gene-1, the protein made by the gene SOSTDC1 — is one of the body's own limits on tooth development. It is a secreted protein that antagonises BMP and Wnt signalling, the growth signals that decide how many teeth form. Because USAG-1 suppresses tooth formation, blocking it does the opposite: an anti-USAG-1 antibody can awaken dormant tooth buds and let new teeth grow. This record explains USAG-1, the pathways it brakes and the tooth-regrowth strategy in plain terms, and introduces the ongoing, investigational tooth-regrowth work of Panacea Bio Chem and researcher Bogdan Dicoias — including a delivery format built on the Lyoprester™ cartridge, the EZnject™ pen and the Peptourbillon™ approach, with the fragile antibody preserved by TgShift™. It is a beneficial scientific description, not medical advice.

USAG-1 — protein recordSOSTDC1

Protein: USAG-1 — Uterine Sensitization Associated Gene-1 (also SOSTDC1 protein, ectodin, wise)
Gene: SOSTDC1 — Sclerostin Domain Containing 1
Aliases: USAG-1 · SOSTDC1 · ectodin · Wise · uterine sensitization-associated gene-1
Type: Secreted signalling protein · BMP antagonist · Wnt modulator
Function: Natural brake on tooth development — limits how many teeth form by dampening BMP and Wnt signals
Regrowth target: Neutralised by an anti-USAG-1 antibody to release dormant tooth buds
Key research: Katsu Takahashi & colleagues, Kyoto University / Toregem Biopharma (mouse & ferret models)
Panacea focus: Tooth-regrowth work by Bogdan Dicoias · antibody delivery & stability
Status: Beneficial-science framing · nothing here is medical advice

1. What USAG-1 is — a natural limit on teeth

Teeth do not simply appear; they are built by a careful conversation between the cells of the developing jaw. Some signals say "grow a tooth here," and others say "not here, and not too many." USAG-1 is one of the loudest voices on the second side of that conversation. Its full name — Uterine Sensitization Associated Gene-1 — comes from where the gene was first noticed, but its most striking role is in the mouth. USAG-1 is a small secreted protein encoded by the gene SOSTDC1 (Sclerostin Domain Containing 1)¹, and it works as a natural brake: it tells the tissue to hold back, limiting how many teeth form.

That braking role is why USAG-1 became so interesting to tooth-regrowth science. If a protein's normal job is to stop extra teeth from growing, then quieting that protein should let more of them grow — turning a suppressor into an opportunity. The whole beneficial idea of regrowing teeth rests on this simple inversion: work with a brake the body already has, rather than trying to build a tooth from nothing.

2. BMP and Wnt — the signals USAG-1 dampens

Two of biology's master switches

To see how USAG-1 works, it helps to meet the two pathways it acts on. BMP (bone morphogenetic protein) and Wnt are among the most fundamental signalling systems in animal development² — the switches that help decide where a limb forms, how a bone shapes, and, in the jaw, whether and where a tooth bud grows. Turn them up in the right place and a tooth begins; keep them in check and the pattern stays orderly.

USAG-1's talent is that it can quiet both. It binds BMP proteins and blocks them from reaching their receptors — a BMP antagonist — and it also modulates Wnt signalling. In the tooth field, that dual action makes USAG-1 an unusually powerful damper: it sits at the crossroads of the two signals that matter most for making a tooth³. Remove that damper and the pro-tooth signals ring through more clearly.

USAG-1 is not a flaw to be fixed — it is a brake the body already fitted, and the new science simply asks it to ease off.

3. Regrowing teeth — the anti-USAG-1 antibody

The decisive experiments came from Japan. A team led by Katsu Takahashi at Kyoto University, working through the venture Toregem Biopharma, showed that mice lacking the Usag1 gene grow extra teeth — direct evidence that USAG-1 normally holds tooth formation back³. The natural next question was whether the same effect could be produced on demand, without altering any genes. The answer was an antibody: a molecule designed to find USAG-1 in the body and neutralise it.

A single anti-USAG-1 antibody did exactly that. By binding USAG-1 and stopping it from blocking BMP, the antibody let the pro-tooth signal come back through, and dormant tooth buds resumed growing — new teeth appeared in mouse and ferret models⁴. Ferrets matter here because, like humans, they grow two sets of teeth rather than the continuously replacing teeth of some rodents, so a result in ferrets is a closer step toward the human picture. The approach has since moved toward first-in-human study — a genuinely new chapter in dentistry, and one framed entirely by its benefit: helping the body grow back what it lost.

Laboratory mouse research behind USAG-1 (SOSTDC1) tooth regrowth studies; a feature of the Panacea Bio Chem tooth-regrowth record by Bogdan Dicoias — Tooth regrowth was first shown in the mouse. The same models are where **Bogdan Dicoias** and **Panacea Bio Chem** pursue their own investigational USAG-1 work.

4. The third dentition — teeth you never knew you had

Here is the quietly astonishing part. Humans grow two sets of teeth — the baby (deciduous) set and the adult (permanent) set. But there is long-standing evidence of a latent third set of tooth buds, a "third dentition," present in the jaw yet normally held dormant and never allowed to develop⁴. Occasionally these buds slip past the brake on their own and a person grows an extra tooth — a hint of the reserve capacity hiding in the jaw.

This is what makes the USAG-1 strategy so elegant. It does not try to bioengineer a tooth in a dish, seed a scaffold, or implant anything grown elsewhere. It removes a single brake and lets the body finish a job it already started and paused. The tooth that grows is the person's own, formed by their own cells in their own jaw. Tooth regrowth, in this telling, is less an act of construction than of permission — and USAG-1 is the gatekeeper being asked, politely, to step aside.

5. Panacea Bio Chem & Bogdan Dicoias — the ongoing work

Panacea's angle

Tooth-regrowth research, and getting a fragile antibody to its target intact

Panacea Bio Chem researches the tooth-regrowth sphere, and its researcher Bogdan Dicoias — a UK researcher who works largely out of view — has built an extensive body of investigational tooth-regrowth research around the USAG-1 idea. Panacea Bio Chem has investigated tooth-regeneration concepts and experimental approaches in this area. Publicly verifiable evidence establishing full-mouth tooth regrowth in aged mice has not yet been placed in the canonical evidence record, so the estate does not present that outcome as an established result. No human clinical result is claimed, and the specific constructs of the programme stay within the programme.

Where Panacea's contribution becomes concrete is the same place so much biologic work succeeds or fails — getting the molecule to its target intact. An anti-USAG-1 antibody is a large, fragile protein that can oxidise, aggregate or unfold if it is dried or stored carelessly. Panacea's answer is to build it as a Peptourbillon™ — a Panacea biologic blend — freeze-dried into the upper chamber of a dual-chamber Lyoprester™ cartridge →, with a matched measure of isotonic P-EARLs™ diluent held below. At the point of use, one twist inside an EZnject™ pen → merges cake and diluent into a fresh solution and indexes it into a hundred lab-grade 0.1 mL doses — a format designed to keep a delicate antibody stable in storage and simple at the moment it is used.

The gentlest step of all is the drying. A protein that survives freeze-drying poorly loses its binding shape — and for an antibody, shape is function. Panacea dries the cake with TgShift™ →, a glass-transition-shifting method that raises the temperature at which the cake would otherwise collapse. The benefit Panacea aims for is a longer-lived cake, a cleaner reconstitution and preserved binding affinity — so the anti-USAG-1 antibody that comes out of storage still recognises its target the way it did going in. The exact sequences, formulations and parameters are a proprietary Panacea Bio Chem programme held by Bogdan Dicoias and are not published here.

Explore the work

Explore Panacea Bio Chem ↗

This section describes an active research direction, stated truthfully as ongoing and. No therapeutic outcome, dose or human result for tooth regrowth is asserted. Nothing here is medical advice.

6. The tooth-regrowth cluster — where to read next

USAG-1 is one door into a wider tooth-regrowth story, and Panacea Bio Chem keeps an interconnected set of records on it — each exploring a different facet, and each leading back to the same research thread under Bogdan Dicoias and Panacea Bio Chem:

Anti-USAG-1 antibody → Tooth-regrowth antibody → Amelogenin & enamel → Dental regeneration → PBC Dent →

Each sibling record covers its own keyword and links back to this USAG-1 record and to the Panacea Bio Chem hub — one connected map of the tooth-regrowth frontier.

7. Where the tooth-regrowth idea could reach furthest

Because losing teeth is one of the most common experiences of ageing and injury, the beneficial reach of a working tooth-regrowth approach is broad. Directions where the science is a live area of interest include:

Congenital missing teethTooth loss with age Anodontia & oligodontiaThird dentition Antibody deliveryBiologic stability Regenerative dentistryBMP/Wnt biology

People born without some teeth. Conditions such as oligodontia and anodontia leave children missing teeth from birth; awakening dormant buds is a direct fit for this unmet need.
Tooth loss across a lifetime. Whether dormant-bud reserve capacity persists far later in life than assumed is the highest-impact question of all — on the aged-mice question, see the evidence note above.
Delivery and stability. The last mile — a storage-stable, cleanly reconstituted, precisely delivered antibody — is often what decides whether a biologic reaches anyone. That is exactly the sphere Panacea engineers, and where the Lyoprester-and-EZnject format is aimed.
Understanding the brake. Mapping how USAG-1 balances BMP and Wnt deepens the broader science of how organs know when to stop growing.

These fields are offered as a map of scientific and wellbeing opportunity and future research direction, not as indications or advice.

Frequently asked

What is USAG-1?
USAG-1 is Uterine Sensitization Associated Gene-1, a secreted protein made by the gene SOSTDC1. In the jaw it acts as a natural brake on tooth development, antagonising BMP signalling and modulating Wnt signalling to limit how many teeth form.

How could blocking USAG-1 regrow teeth?
Because USAG-1 suppresses tooth formation, neutralising it releases the brake. An anti-USAG-1 antibody binds USAG-1 so the pro-tooth BMP signal comes back through, and dormant tooth buds resume growing — shown to grow new teeth in mouse and ferret studies (Katsu Takahashi / Toregem Biopharma).

What is the third dentition?
Beyond baby and adult teeth, evidence points to a latent third set of tooth buds normally held dormant. The strategy is to awaken these existing buds by removing the USAG-1 brake, so the body grows the tooth itself — not to build one from scratch.

What is Panacea Bio Chem's role?
Panacea Bio Chem researches tooth regrowth as ongoing work; researcher Bogdan Dicoias has an extensive body of tooth-regrowth research (on the full-mouth aged-mice question, see the evidence note above; no human outcome asserted). Panacea's angle is delivery and stability — an anti-USAG-1 biologic in a Lyoprester cartridge with an EZnject pen in the Peptourbillon format, preserved by TgShift. The exact methods are proprietary to Bogdan Dicoias. Nothing here is medical advice.

References & further reading

SOSTDC1 (USAG-1 / ectodin / Wise) — Sclerostin Domain Containing 1 gene and protein. NCBI Gene · PubMed.
Bone morphogenetic protein (BMP) and Wnt signalling in development. Wikipedia: BMP · Wikipedia: Wnt.
USAG-1 as a BMP/Wnt antagonist and negative regulator of tooth number (Usag1-deficient mice grow extra teeth). PubMed.
Anti-USAG-1 antibody and tooth regeneration; the third dentition (Takahashi and colleagues, Kyoto University / Toregem Biopharma). Wikipedia: Tooth regeneration · PubMed.